 (Chest 1994; 106:1843-50) 
Adaptive lung ventilation uses synchronized intermittent pressure-controlled ventilation as its basic mode. The user chooses a desired gross alveolar ventilation (V'gA in liters per minute) and the ALV controller partitions the alveolar ventilation into a target volume and a target rate and then adjusts inspired pressure support, ventilator rate, and inspired/ expired time ratio to achieve the desired V'gA. The adjustments are based on measurements of the patient's lung mechanics and series dead space (VdS), and are designed to achieve minimal work of breathing and avoid intrinsic PEEP. The adjustments occur gradually without significant overshoot, the maximal breath to breath change of inspiratory pressure is 1 cm H20 per breath. The ALV controller starts with a sequence of five test breaths of 15 cm H20 above PEEP, an inspiratory time of 1 s, and a synchronized mechanical ventilatory rate of 15/min to measure expiratory time constant (RC), and the patients' series dead space (similar to anatomic dead space). Adaptive lung ventilation then starts to adjust the mechanical rate and inspired pressure-level to meet the prescribed goals. To optimize the controller performance, the volume controller gain is continuously adapted to the patient's susceptibility to inspiratory pressure (effective lung compliance and resistance). The RC and VdS are also updated breath by breath but for safety reasons the controller continues to use the initial VdS data calculated with the five test breaths. The ALV controller and the input/output relationships are depicted in Figure 1 .
The Our institutional ethical research committee approval was obtained before commencing the study and informed consent was obtained from each patient prior to entering them into the study.
Three groups of patients were studied: group 1 -normal lungs; group 2-pulmonary parenchymal abnormality; and group 3-chronic obstructive pulmonary disease ( Table 1 ). The patients were initially ventilated for at least 30 min using the same mode and settings on which each patient had been ventilated during the mechanical ventilatory period. In this baseline condition, gross alveolar ventilation (V'gA in liters per minute) was measured as respiratory rate (f) times tidal volume (VT) minus series dead space ventilation (fCVT-f'VdS) at baseline. The ventilator was then switched to ALV with a target V'gA identical to the baseline condition. After 30 min, the target V'gA was reduced by 66% to encourage weaning. If after 2 h a patient required no more than 5 cm of pressure support and no more than four mechanical ventilatory breaths while still meeting the standard weaning criteria, the patient was considered to be weaned. He or she was then placed on a T-piece for another 24 h. The wean was documented as being successful if the patient required no further ventilatory support and continued to meet the standard wean criteria after 24 h. The wean was considered to have failed if the patient continued to require more than 5-cm pressure support or more than four mechanical breaths or no longer met the weaning criteria, eg, PaCO2 increased to >6 kPa, respiratory rate increased to >30/ min, etc. The wean was also documented as having failed if the patient required further ventilatory support after an apparently successful wean.
To document the weaning process, recordings of ventilatory parameters (see below), hemodynamic parameters, and arterial blood gases were made at baseline, after 5 min on ALV, at 30 min, and then at 2 h intervals. The patients were also continuously monitored by ECG, pulse oximetry, and capnography.
Results 
RESULTS
The 27 patients studied ranged in age from 20 to 74 years (mean, 44 years) and had been ventilated in our RICU for respiratory failure for 1 to 30 days (mean, 7.7 days). We included nine patients with normal lungs (mean Apache IL score on admission: 13.2), nine patients with parenchymal lung disease (mean Apache II score on admission: 14.6) and nine patients with severe chronic obstructive lung disease (mean Apache II score on admission: 18.7). Patient data and primary diagnoses are given in Table 1 .
Baseline data results are summarized in Table 2 . The only statistically significant difference in any of the parameters measured at baseline and between the three patient disease groups was a lower end expiratory airway pressure (2 cm H20) in the COPD group. Although VC, Rtot, RC, IPD, and slope CO2 were noticeably different between the disease groups, the differences did not reach statistical significance due to the application of the Bonferroni correction.
The outcome of the weaning is depicted in Figure  2 . In the group with normal lungs, the ALV controller reduced the respiratory support to the minimum within 30 min. Eight patients were successfully weaned whereas one patient who had been septicemic and had residual muscle weakness became tachypneic some hours after the wean, requiring further ventilation, and he was documented as having failed the wean. In the group with parenchymal lung disease, seven patients were successfully weaned; one patient who had reduced pulmonary compliance after septicemia and transfusion-related acute lung injury failed the wean, while one patient who required reventilation for worsening hypoxemia 24 h after being weaned and was subsequently confirmed to have a fibrosing alveolitis was not able to be assessed. Table 4 and Figure 3 show that the ALV controlThis patient was excluded from further analysis. In ler reduced the APinsp to 5 cm H20 in the successthe COPD group, six patients were successfully fully weaned patients but maintained an elevated weaned whereas in three patients, the ALV controlpressure support level in all but one patient who ler maintained pressure support respiration and these failed to wean. were documented as having failed the wean. HowDifferences were recorded in the index of airway ever, apart from the patient in the pulmonary resistance relative to muscular activity (Rtot), the parenchymal group who was unable to be assessed, respiratory drive (P0.1), the IPD, and the pressure the patients in the three groups who failed the weans time product (PE) as well as the slope of the CO2 at the time of this study were subsequently weaned curve between the failed and successfully weaned from ventilatory support and recovered from their patients. However, the differences did not reach staacute disease that had caused the respiratory failure.
tistical significance and the null hypotheses was ac- Table 3 shows a comparison between the successcepted for these parameters.
ful and failed wean cases at baseline. The differences None of the patients studied complained of any seen in Pawmax, Rtot, P0.1, IPD, PE, and VdS were discomfort during their weaning by the ALV connot statistically significant.
troller and none reported shortness of breath in the value of 33% of the measured value is introduced. In fact, the IPD, P0.1, and PE values are higher in the successfully weaned patients than in the failed-towean patients which indicates that the former already did an increased amount of work of breathing despite the high respiratory support given to them at baseline. However, further work is necessary to clarify the strategy of V'gA setting.
It is interesting that the patients who failed the wean were not hypoventilated despite the reduced V'gA target and the poor patient activity. In fact, ALV maintained a V'gA significantly larger than the target value. This is probably an effect of the V'gA partitioning (model of Otis), which is strongly affected by RC and VdS yet to a much lesser extent by the target V'gA. The latter influences more the respiratory rate. Since ALV allows the trigger of more breaths than actually targeted and the patients in this study were able to do so, an appropriate V'gA could always be achieved. If, in such a situation, the patients would have been paralyzed or otherwise kept from triggering breaths, V'gA would have dropped to the target value and the patients would have been hypoventilated.
It is a requirement of all currently practiced weaning techniques that a clinician should decide on the time of the initiation of a wean based on clinical evidence of the likelihood that the wean will be successful. Currently accepted weaning criteria include evidence of resolution of lung disease, adequate gas exchange, and respiratory muscle strength and reserve.11-4,20,21 In most ventilated patients, when these criteria are confidently met, weaning is often a simple task.22-24 However, in some patients who have been critically ill and have been ventilated for some time, or in those who have underlying lung abnormality, the weaning criteria may be barely met and thus not have sufficient predictive value."1',23 '25'26 This situation requires more sensitive and specific predictors that may depend on the underlying pulmonary disease. In this study, the differences seen in VdS, Pawmax, Rtot, P0.1, IPD, and PE at baseline between the failed and successfully weaned patients suggest that combinations of these indices might turn out to be potentially useful predictors of outcome. We believe that an index of increased airway resistance related to respiratory muscle capability may be a sensitive and specific predictor of outcome of weaning in patients with COPD. It has suggested by other authors that a rapid shallow breathing index (f/VT) would have high predictive value." Although this may be the case in reduced pulmonary compliance, it cannot be supported by our data for patients with COPD.
In summary, this study describes 21 patients who were successfully and appropriately weaned by an ALV controller as well as 4 patients who were identified as not weanable by the ALV controller and appropriately supported. Only one patient could be considered to have possibly been inappropriately weaned by the ALV controller down to a pressure support level of 5 cm H20, because he became tachypneic on the T-piece some hours after the wean and required further ventilation. However, the ALV controller is designed to respond adequately to tachypnea by increasing the pressure support level and it is likely that this patient would have been safely ventilated by the controller when this occurred. Although most patients who meet standard weaning criteria are easily weaned from mechanical ventilatory support, this cannot be guaranteed and the occasional patient will have a deteriorating condition during a weaning attempt requiring increased respiratory support. The ALV controller has the potential to provide a safe efficient wean in all forms of lung disease because, although a patient may "fail" to wean, the ALV controller will continually test the patient's weaning capability while ensuring adequate optimal alveolar ventilation in the most suitable form. In contrast to MMV ventilation, ALV is designed to adjust ventilation until optimal gross alveolar ventilation is achieved. Inherent in the design of ALV is the ability to prevent excessive dead space ventilation, avoid inadvertent PEEP, and discourage rapid shallow breathing. No patient in our study was placed at any risk in the attempted weaning by the ALV controller and yet we were able to document which patients were unable to be weaned within 2 h. This information was not possible to be obtained from any patient before commencing each wean despite the use of standard weaning criteria for documenting the likelihood of a successful wean.
Further studies are required to confirm that the target gross alveolar ventilation (V'gA) of 33% of the measured baseline V'gA, as chosen in this study, is appropriate in automatic weaning using the ALV controller. We believe that the ALV controller may be useful to indicate the time for safe weaning sooner in patient care and may also assist in documenting the reasons for failed or difficult weaning. These aspects of the ALV controllers' clinical applications are currently being studied and will be reported as soon as completed.
